N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine,
SQ 109,
SQ-109,
SQ109 compound,
SQ109,
SQ-109,
502487-67-4,
SQ 109,
UNII-9AU7XUV31A,
9AU7XUV31A,
CHEMBL561057,
N'-(2-adamantyl)-N-[(2E)-3,7-dimethylocta-2,6-dienyl]ethane-1,2-diamine,
N-[(2e)-3,7-Dimethylocta-2,6-Dien-1-Yl]-N'-[(1r,3s,5r,7r)-Tricyclo[3.3.1.1~3,7~]dec-2-Yl]ethane-1,2-Diamine,
NSC 722041,
AC1NRWTN,
N-Geranyl-N'-(2-adamantyl)ethane-1,2-diamine,
GTPL7997,
SCHEMBL1780846,
SCHEMBL1780848,
SCHEMBL10050752,
SCHEMBL19630696,
EX-A764,
JFIBVDBTCDTBRH-REZTVBANSA-N,
BCP22030,
BDBM50388398,
NSC722041,
ZINC39959796,
AKOS030526825,
SQ109 /SQ-109,
CS-1188,
DB05186,
HY-14989,
SQ109, >=98% (HPLC),
W-5467,
NSC 722041;SQ-109;SQ 109,
J-690310,
1,2-Ethanediamine, N-[(2E)-3,7-dimethyl-2,6-octadienyl]-N'-tricyclo[3.3.1.13,7]dec-2-yl-,
1,2-Ethanediamine, N1-((2E)-3,7-dimethyl-2,6-octadien-1-yl)-N2-tricyclo(3.3.1.13,7)dec-2-yl-,
Cardiogenol C hydrochloride,
D0K8DI,
Second-generation EMB, Sequella,
AIDS207396,
SQ-37,
SQ-59,
Antibiotics (tuberculosis), Sequella,
Second-generation ethambutol, Sequella,
CID5274428,
A3834,
3RX,